Abstract:Diabetes mellitus is characterized by hyperglycemia that makes insulin more prone to glycation and form advanced glycation end products (AGEs). Here, we report the effect of glyoxal (GO) on the formation of AGEs using human insulin as model protein and their structural modifications. The present investigation also reports the anti-AGE potential of Heliotropium bacciferum (Leaf) extracts. The phytochemical analysis of H. bacciferum revealed that free phenolic extract contains higher amount of total phenolic (3901.58 ± 17.06 mg GAE/100 g) and total flavonoid content (30.41 ± 0.32 mg QE/100 g) when compared to bound phenolic extract. Naringin and caffeic acid were identified as the major phenolic ingredients by UPLC-PAD method. Furthermore, bound phenolics extract showed significantly higher DPPH and superoxide radicals scavenging activity (IC50 17.53 ± 0.36 μg/mL and 0.306 ± 0.038 mg/ mL, respectively) (p ≤ 0.05). Besides, the bound phenolics extract also showed significant (p ≤ 0.05) chelating power (IC50 0.063) compared to free phenolic extract. In addition, bound phenolic extract could efficiently trap GO under physiological conditions. Spectroscopic investigation of GO-modified insulin illustrated changes in the tertiary structure of insulin and formation of AGEs. On the other hand, no significant alteration in secondary structure was observed by far UV-CD measurement. Furthermore, H. bacciferum extract inhibited α-glucosidase activity and AGEs formation implicated in diabetes. Molecular docking analysis depicted that GO bind with human insulin in both chains and forms a stable complex with TYR A: 14, LEU A:13, ASN B:3, SER A:12 amino acid residues with binding energy of - 2.53 kcal/mol. However, caffeic acid binds to ASN A:18 and GLU A:17 residues of insulin with lower binding energy of -4.67 kcal/mol, suggesting its higher affinity towards human insulin compared to GO. Our finding showed promising activity of H. bacciferum against AGEs and its complications. The major phenolics like caffeic acid, naringin and their derivatives could be exploited for the drug development for management of AGEs in diabetes.

Effect of Ellagitannin Metabolites Ellagic Acid and Urolithins A-D on the Non-Enzymatic Glycation of Human Serum Albumin and Inhibiting Mechanisms

Inhibitory Effects of Hydroxysafflor Yellow A on the Formation of Advanced Glycation End Products in Vitro.

Urolithin A Alleviates Advanced Glycation End-Product Formation by Altering Protein Structures, Trapping Methylglyoxal and Forming Complexes.

Hydroxysafflor Yellow A Protects Methylglyoxal-Induced Injury in the Cultured Human Brain Microvascular Endothelial Cells

Effect of (-)-epigallocatechin-3-gallate on glucose-induced human serum albumin glycation

Mechanism of interaction between urolithin A and α -glucosidase: Analysis by inhibition kinetics, fluorescence spectroscopy, isothermal titration calorimetry and molecular docking

Bioactive anthraquinones found in plant foods interact with human serum albumin and inhibit the formation of advanced glycation endproducts

Effect of Glycation Derived from Α-Dicarbonyl Compounds on the in Vitro Digestibility of Ovalbumin: Tracing of Advanced Glycation End-Products and Immuno-Active Peptides

Biophysical insight into the binding mechanism of epigallocatechin-3-gallate and cholecalciferol to albumin and its preventive effect against AGEs formation: An in vitro and in silico approach

Influence of Human Serum Albumin Glycation on the Binding Affinities for Natural Flavonoids

Inhibitory effect of epicatechin gallate on protein glycation

Effects of Myricetin and Its Derivatives on Nonenzymatic Glycation: A Mechanism Study Based on Proteomic Modification and Fluorescence Spectroscopy Analysis

Inhibitory Effect of Artemisia selengensis Straw Flavonoids on the Formation of Advanced Glycation End Products (AGEs)

The Inhibitory Effects of Natural Antioxidants on Protein Glycation As Well As Aggregation Induced by Methylglyoxal and Underlying Mechanisms

Comparative Study on the Antioxidative Effects and Α-Glucosidase Inhibitory Potential in Vitro among Ellagic Acid and Its Metabolites Urolithins

Inhibitory Effects of Alcohol Extracts from 22 Specie of Herbs on Nonenzymatic Glycosylation in Vitro

The inhibition of oleanolic acid on protein non-enzymatic glycation

Ameliorative Effect of Ellagic Acid on Aging in Rats with the Potential Mechanism Relying on the Gut Microbiota and Urolithin A-Producing Ability

Mechanisms of inhibition of advanced glycation end-products (AGEs) and α-glucosidase by Heliotropium bacciferum: Spectroscopic and molecular docking analysis

Comprehensive Glycomic Analysis Reveals That Human Serum Albumin Glycation Specifically Affects the Pharmacokinetics and Efficacy of Different Anticoagulant Drugs in Diabetes.

Inhibition on α-Glucosidase Activity and Non-Enzymatic Glycation by an Anti-Oxidative Proteoglycan from Ganoderma lucidum